Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma

Abstract Hepatocellular carcinoma (HCC) is the leading cause of cancer-related death worldwide, because recurrence often occurs in most HCC patients undergoing hepatectomy. It is necessary to identify patients with high risk for recurrence and adopt effective therapies. An obstacle to monitor patien...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Binghua Li, Wendu Feng, Ouyang Luo, Tiancheng Xu, Yajuan Cao, Hongyan Wu, Decai Yu, Yitao Ding
Format: article
Langue:EN
Publié: Nature Portfolio 2017
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/00143853c4ef4ec2ba9214ccd9394d38
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!